摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

[4-benzenesulfonyl-2-(2-chlorophenyl)oxazol-5-yl]-dimethylamine | 301158-50-9

中文名称
——
中文别名
——
英文名称
[4-benzenesulfonyl-2-(2-chlorophenyl)oxazol-5-yl]-dimethylamine
英文别名
4-(benzenesulfonyl)-2-(2-chlorophenyl)-N,N-dimethyl-1,3-oxazol-5-amine
[4-benzenesulfonyl-2-(2-chlorophenyl)oxazol-5-yl]-dimethylamine化学式
CAS
301158-50-9
化学式
C17H15ClN2O3S
mdl
——
分子量
362.837
InChiKey
ZGOUDMAXJJTRQS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.2
  • 重原子数:
    24
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.12
  • 拓扑面积:
    71.8
  • 氢给体数:
    0
  • 氢受体数:
    5

文献信息

  • SULFONYLOXAZOLAMINE ALS THERAPEUTISCHE WIRKSTOFFE
    申请人:MERCK PATENT GmbH
    公开号:EP1140875A1
    公开(公告)日:2001-10-10
  • METHODS FOR IDENTIFYING INHIBITORS OF SOLUTE TRANSPORTERS
    申请人:Verkman Alan S.
    公开号:US20100190796A1
    公开(公告)日:2010-07-29
    Provided herein are methods for identifying and characterizing agents that alter the volume of a cell. Methods are provided for rapid screening and identification of an agent that alters the capability of a small, neutrally charged solute transporter to transport the solute across a cell membrane. The methods described herein may be used to identify and characterize inhibitors of urea transporters, to identify and characterize inhibitors of aquaporins, and to identify and characterize inhibitors of other small, neutrally charged solutes such as glucose.
  • PHENYLSULFOXYOXAZOLE COMPOUND INHIBITORS OF UREA TRANSPORTERS
    申请人:Verkman Alan S.
    公开号:US20100305105A1
    公开(公告)日:2010-12-02
    Provided herein are small molecule compounds that alter the transport activity of solute transporters, particularly urea transporters. The compounds described herein belong to the phenylsulfoxyoxazole, phenylsulfoxyimidazole, phenylsulfoxythiazole class of compounds. The compounds described herein are useful for increasing solute clearance in states of fluid overload and for treating cardiovascular, renal, and metabolic diseases, disorders, and conditions. Methods for identifying and using these agents that inhibit urea transporters are described herein.
  • US6441013B1
    申请人:——
    公开号:US6441013B1
    公开(公告)日:2002-08-27
  • US8394788B2
    申请人:——
    公开号:US8394788B2
    公开(公告)日:2013-03-12
查看更多